New Delhi, March 31 Novo Nordisk India announced on Tuesday reductions in the prices of Ozempic and Wegovy in India, days after the launch of generic versions of semaglutide injections for patients with type 2 diabetes and obesity.Indian pharmaceutical companies recently announced the launch...